Canagliflozin
ATC A10BK02 · 9 markets · 97 records
CN 27 records · 2 strengths
- 100 mgtablet怡可安卡格列净Manufacturer: 四川科伦药业股份有限公司、Manufacturer: 山东凤凰制药股份有限公司、Manufacturer: 常州恒邦药业有限公司、Manufacturer: 杭州中美华东制药有限公司、Manufacturer: 正大天晴药业集团股份有限公司、Manufacturer: 江苏德源药业股份有限公司、Manufacturer: 浙江华义制药有限公司、Manufacturer: 湖北华世通生物医药科技有限公司 +1
- 300 mgtablet怡可安卡格列净Manufacturer: 四川科伦药业股份有限公司、Manufacturer: 常州恒邦药业有限公司、Manufacturer: 杭州中美华东制药有限公司
US 15 records · 6 strengths
CA 15 records · 4 strengths
- 100 mgtabletAG-CANAGLIFLOZINAPO-CANAGLIFLOZIN、AURO-CANAGLIFLOZIN、INVOKANA、JAMP CANAGLIFLOZIN、SANDOZ CANAGLIFLOZIN
- 300 mgtabletAG-CANAGLIFLOZINAPO-CANAGLIFLOZIN、AURO-CANAGLIFLOZIN、INVOKANA、JAMP CANAGLIFLOZIN、SANDOZ CANAGLIFLOZIN
- 50 mgtabletINVOKAMET
- 150 mgtabletINVOKAMET
GB 14 records · 3 strengths
- 100 mgtabletINVOKANAManufacturer: Colorama Pharmaceuticals Ltd、Manufacturer: J M McGill Ltd、Manufacturer: Niche Pharma Ltd
- 300 mgtabletINVOKANAManufacturer: Colorama Pharmaceuticals Ltd
- 50 mgtabletVokanamet 50mg/850mg tablets
ES 9 records · 4 strengths
- 100 mgtabletINVOKANA
- 300 mgtabletINVOKANA
- 1,000 mgtabletVokanamet 50mg/850mg tablets
- 850 mgtabletVokanamet 50mg/850mg tablets
SG 2 records · 2 strengths
- 100 mgtabletINVOKANA™ FILM-COATED TABLETS 100 MG
- 300 mgtabletINVOKANA™ FILM-COATED TABLETS 100 MG
HK 2 records · 1 strengths
Records without a stated strength · 1 INVOKANA
EU 2 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 INVOKANA、Vokanamet 50mg/850mg tablets
TW 1 records · 1 strengths
- 100 mgtabletCANAGLU Tablets 100mg可拿糖膜衣錠100毫克
| Strength / form / release | US | GB | CA | SG | CN | ES | TW | HK | EU |
|---|---|---|---|---|---|---|---|---|---|
| 100 mgRecorded as: 0.1 g tablet | INVOKANA | Manufacturer: Colorama Pharmaceuticals Ltd ×2 Manufacturer: J M McGill Ltd Manufacturer: Niche Pharma Ltd+1INVOKANA | AG-CANAGLIFLOZIN APO-CANAGLIFLOZIN AURO-CANAGLIFLOZIN | INVOKANA™ FILM-COATED TABLETS 100 MG | Manufacturer: 四川科伦药业股份有限公司 ×2 Manufacturer: 山东凤凰制药股份有限公司 ×4 Manufacturer: 常州恒邦药业有限公司 ×4+7Manufacturer: 杭州中美华东制药有限公司 ×2 Manufacturer: 正大天晴药业集团股份有限公司 Manufacturer: 江苏德源药业股份有限公司 ×6 Manufacturer: 浙江华义制药有限公司 ×2 Manufacturer: 湖北华世通生物医药科技有限公司 ×3 Manufacturer: 齐鲁制药有限公司 怡可安卡格列净 | INVOKANA | CANAGLU Tablets 100mg 可拿糖膜衣錠100毫克 | ||
| 300 mgRecorded as: 0.3 g tablet | INVOKANA | Manufacturer: Colorama Pharmaceuticals Ltd ×2 INVOKANA | AG-CANAGLIFLOZIN APO-CANAGLIFLOZIN AURO-CANAGLIFLOZIN | INVOKANA™ FILM-COATED TABLETS 100 MG | Manufacturer: 四川科伦药业股份有限公司 ×2 Manufacturer: 常州恒邦药业有限公司 ×4 Manufacturer: 杭州中美华东制药有限公司 ×2+1怡可安卡格列净 | INVOKANA | |||
| 50 mg tablet | INVOKAMET | Vokanamet 50mg/850mg tablets | INVOKAMET | ||||||
| 150 mg tablet | INVOKAMET | INVOKAMET | |||||||
| 1,000 mg tablet | Vokanamet 50mg/850mg tablets | ||||||||
| 850 mg tablet | Vokanamet 50mg/850mg tablets | ||||||||
| 150 mg tablet · extended-release | INVOKAMET | ||||||||
| 50 mg tablet · extended-release | INVOKAMET | ||||||||
unknown | INVOKANA | INVOKANA Vokanamet 50mg/850mg tablets |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
3 more strength/form rows are recorded only in ES · HK · EU and are not shown in this table. Hay 3 filas de concentración/forma registradas solo en ES · HK · EU que no se muestran en esta tabla. 另有 3 个规格/剂型仅在 ES · HK · EU 有记录(未在本表显示)。 另有 3 個規格/劑型僅在 ES · HK · EU 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.